OptimalTTF-1: Enhancing tumor treating fields therapy with skull remodeling surgery. A clinical phase I trial in adult recurrent glioblastoma.
Anders Rosendal KorshoejSlavka LukacovaYasmin Lassen-RamshadChristian RahbekKåre Eg SeverinsenTrine Lignell GuldbergNikola MikicMette Haldrup JensenSøren Ole Stigaard CortnumGorm von OettingenJens Christian Hedemann SørensenPublished in: Neuro-oncology advances (2020)
TTFields therapy combined with SR-surgery and medical oncological treatment is safe and nontoxic and holds the potential to improve the outcome for GBM patients through focal dose enhancement in the tumor.
Keyphrases
- minimally invasive
- coronary artery bypass
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- prognostic factors
- peritoneal dialysis
- surgical site infection
- study protocol
- stem cells
- prostate cancer
- patient reported outcomes
- robot assisted
- climate change
- rectal cancer
- human health
- open label